Literature DB >> 11476837

Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images.

N C Fox1, W R Crum, R I Scahill, J M Stevens, J C Janssen, M N Rossor.   

Abstract

BACKGROUND: Early diagnosis and monitoring of the progression of Alzheimer's disease is important for the development of therapeutic strategies. To detect the earliest structural brain changes, individuals need to be studied before symptom onset. We used an imaging technique known as voxel-compression mapping to localise progressive atrophy in patients with preclinical Alzheimer's disease.
METHODS: Four symptom-free individuals from families with early-onset Alzheimer's disease with known autosomal dominant mutations underwent serial magnetic resonance imaging (MRI) over 5-8 years. All four became symptomatic during follow-up. 20 individuals with a clinical diagnosis of probable Alzheimer's disease and 20 control participants also underwent serial MR imaging. A non-linear fluid matching algorithm was applied to register repeat scans onto baseline imaging. Jacobian determinants were used to create the voxel-compression maps.
FINDINGS: Progressive atrophy was revealed in presymptomatic individuals, with posterior cingulate and neocortical temporoparietal cortical losses, and medial temporal-lobe atrophy. In patients with known Alzheimer's disease, atrophy was widespread apart from in the primary motor and sensory cortices and cerebellum, reflecting the clinical phenomenology.
INTERPRETATION: Voxel-compression maps confirmed early involvement of the medial temporal lobes, but also showed posterior cingulate and temporoparietal cortical losses at presymptomatic stage. This technique could be applied diagnostically and used to monitor the effects of therapeutic intervention.

Entities:  

Mesh:

Year:  2001        PMID: 11476837     DOI: 10.1016/S0140-6736(01)05408-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  139 in total

Review 1.  A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile.

Authors:  Konstantine K Zakzanis; Simon J Graham; Zachariah Campbell
Journal:  Neuropsychol Rev       Date:  2003-03       Impact factor: 7.444

2.  Normal age-related brain morphometric changes: nonuniformity across cortical thickness, surface area and gray matter volume?

Authors:  Herve Lemaitre; Aaron L Goldman; Fabio Sambataro; Beth A Verchinski; Andreas Meyer-Lindenberg; Daniel R Weinberger; Venkata S Mattay
Journal:  Neurobiol Aging       Date:  2010-08-23       Impact factor: 4.673

3.  Magnetic resonance imaging volume of the angular gyri predicts financial skill deficits in people with amnestic mild cognitive impairment.

Authors:  H Randall Griffith; Christopher C Stewart; Luke E Stoeckel; Ozioma C Okonkwo; Jan A den Hollander; Roy C Martin; Katherine Belue; Jacquelynn N Copeland; Lindy E Harrell; John C Brockington; David G Clark; Daniel C Marson
Journal:  J Am Geriatr Soc       Date:  2010-01-26       Impact factor: 5.562

4.  Brain metabolic correlates of decision making in amnestic mild cognitive impairment.

Authors:  H Randall Griffith; Ozioma C Okonkwo; Jan A den Hollander; Katherine Belue; Jacqueline Copeland; Lindy E Harrell; John C Brockington; David G Clark; Daniel C Marson
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2010-04-06

Review 5.  Potential predictors of hippocampal atrophy in Alzheimer's disease.

Authors:  Vikas Dhikav; Kuljeet Anand
Journal:  Drugs Aging       Date:  2011-01-01       Impact factor: 3.923

6.  Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's disease.

Authors:  Liana G Apostolova; Kristy S Hwang; Luis D Medina; Amity E Green; Meredith N Braskie; Rebecca A Dutton; Jeffrey Lai; Daniel H Geschwind; Jeffrey L Cummings; Paul M Thompson; John M Ringman
Journal:  Dement Geriatr Cogn Disord       Date:  2011-09-23       Impact factor: 2.959

7.  Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls.

Authors:  Yi-Yu Chou; Natasha Leporé; Christina Avedissian; Sarah K Madsen; Neelroop Parikshak; Xue Hua; Leslie M Shaw; John Q Trojanowski; Michael W Weiner; Arthur W Toga; Paul M Thompson
Journal:  Neuroimage       Date:  2009-02-21       Impact factor: 6.556

8.  Finding imaging patterns of structural covariance via Non-Negative Matrix Factorization.

Authors:  Aristeidis Sotiras; Susan M Resnick; Christos Davatzikos
Journal:  Neuroimage       Date:  2014-12-12       Impact factor: 6.556

Review 9.  Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?

Authors:  Robert E Becker; Nigel H Greig; Ezio Giacobini
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

10.  Complexity and synchronicity of resting state blood oxygenation level-dependent (BOLD) functional MRI in normal aging and cognitive decline.

Authors:  Collin Y Liu; Anitha P Krishnan; Lirong Yan; Robert X Smith; Emily Kilroy; Jeffery R Alger; John M Ringman; Danny J J Wang
Journal:  J Magn Reson Imaging       Date:  2012-12-07       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.